Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05295719 · ClinicalTrials.gov registry record · NA
Combining HIIT and n-3 PUFA to Reduce Inflammation and Improve Metabolic Health
A NA study, sponsored by Texas Tech University.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
NCT05295719: Completed NA study, sponsored by Texas Tech University.
NCT05295719 is a NA study that has completed, run by Texas Tech University. The registered enrollment target is 129 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05295719, a NA study, has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
Study Summary
The goal of this project is to understand the combined effects of fish oil and exercise in obesity-associated inflammation. The investigators hypothesize that fish oil will improve gut bacteria profiles, which will in turn potentiate the benefits of an exercise program and improve energy utilization and reduce inflammation and metabolic risk.
Primary Outcome
Serum high-sensitivity C-reactive protein (hs-CRP; mg/L)
Interventions
- BEHAVIORAL High-Intensity Interval Training
- DIETARY_SUPPLEMENT Omega-3 polyunsaturated fatty acid
- DIETARY_SUPPLEMENT Safflower oil
- BEHAVIORAL Low-intensity training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT05295719 record still lists
NCT05295719 is an interventional study that assigns participants to a tested intervention. The registered 129 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 4 interventions - of which High-Intensity Interval Training is the first listed.
NCT05295719 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05295719 about?
NCT05295719 is a clinical study titled "Combining HIIT and n-3 PUFA to Reduce Inflammation and Improve Metabolic Health". The goal of this project is to understand the combined effects of fish oil and exercise in obesity-associated inflammation. The investigators hypothesize that fish oil will improve gut bacteria profiles, which will in turn potentiate the benefits of an exercise program and improve energy utilization...
What is the current status of trial NCT05295719?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2022-09-01. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05295719?
The interventions under investigation include: High-Intensity Interval Training (BEHAVIORAL), Omega-3 polyunsaturated fatty acid (DIETARY_SUPPLEMENT), Safflower oil (DIETARY_SUPPLEMENT), Low-intensity training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05295719?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05295719's enrollment target sits among peer trials
129 744th of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03619850 · 129 participants · Phase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
- NCT05704361 · 129 participants · Phase 1
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
- NCT05919849 · 129 participants · Phase 1
Supporting Parents in Affirming Their Children's Experiences of Stigma
- NCT06313749 · 129 participants · NA
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI